Cargando…
Epigenetic deregulation of BORIS and CTCF in breast cancer
Autores principales: | Alcalá Moreno, Iliana, Soto-Reyes, Ernesto, Morales-Espinosa, Daniela, Barrios, Rodrigo González, Maldonado-Martinez, Hétor Aquiles, Cantú de León, David, Guerra-Calderas, Lissania, Castro, Clementina, Herrera, Luis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600741/ http://dx.doi.org/10.1186/1756-8935-6-S1-P1 |
Ejemplares similares
-
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
por: Salgado-Albarrán, Marisol, et al.
Publicado: (2019) -
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
por: Guerra-Calderas, Lissania, et al.
Publicado: (2018) -
The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective
por: Hernández-Romero, Itzel Alejandra, et al.
Publicado: (2019) -
The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes
por: Hore, Timothy A., et al.
Publicado: (2008) -
Disruption of CTCF at the miR-125b1 locus in gynecological cancers and breast cancer cell lines
por: Soto-Reves, Ernesto, et al.
Publicado: (2013)